Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. (Q37078109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Fabio Marra

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Massimo Pinzani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Umberto Arena

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

95-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18253138%20AND%20SRC:MED&resulttype=core&format=json

Sampling variability of liver fibrosis in chronic hepatitis C.

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

An appraisal of the histopathological assessment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Fibrosis in chronic liver diseases: diagnosis and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Technology evaluation: A critical step in the clinical utilization of novel diagnostic tests for liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

A novel panel of blood markers to assess the degree of liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Shear elasticity probe for soft tissues with 1-D transient elastography.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Transient elastography: a valid alternative to biopsy in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Liver fibrosis in overweight patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Utility of a new model to diagnose an alcohol basis for steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1025

7 January 2021